ARCHIVES

Survivors With Gene Variant At More Risk For Heart Disease

This article is from The Cancer Letter archive.

Vol. 33 No. 6 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

NCI Sponsors Session At ASCO On Clinical Grant Applications

May 3, 1991

ZBB Considered Useless By NCI Staff (Privately)’ New Approach Groups Program Into Four Categories

October 6, 1978

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Payline For 1988 Would Be Around 160 With President’s Budget

January 16, 1987

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004